GO:0070119 ciliary neurotrophic factor binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070119 (ciliary neurotrophic factor binding) is a molecular_function term defined as binding to the cytokine ciliary neurotrophic factor (CNTF).
• CNTF binding is mediated by a receptor complex that includes CNTFRα, gp130, and LIFRβ, and can also involve the interleukin-6 receptor in certain cell types.
• CNTF binding activates downstream signaling such as the JAK/STAT3 pathway, which is critical for neuronal survival and regeneration.
• Dysregulation of CNTF binding and signaling is implicated in motoneuron disease, peripheral nerve injury, and retinal degeneration.
• Key research models include knockout mice, point-mutation knock-in cell lines, and overexpression systems to dissect CNTF binding specificity.
• EDITGENE provides CRISPR-based services to study CNTF binding, including knockout, point mutation, knock-in, overexpression, and library screening.
Description
Ciliary neurotrophic factor binding (GO:0070119) is a molecular function that describes the specific interaction between the cytokine ciliary neurotrophic factor (CNTF) and its binding partners, primarily the CNTF receptor α (CNTFRα). This binding event is the first step in a signaling cascade that regulates neuronal survival, differentiation, and gene expression in various cell types, including motor neurons, sympathetic neurons, and adipocytes. Understanding CNTF binding is essential for elucidating how this cytokine exerts its pleiotropic effects in development and disease. The QuickGO definition states that this term represents binding to the cytokine ciliary neurotrophic factor. CNTF is a member of the interleukin-6 family of cytokines, and its binding to receptors triggers downstream phosphorylation events that activate the JAK/STAT pathway. This molecular function is not limited to the nervous system; CNTF binding also occurs in hepatocytes and muscle cells, where it modulates acute-phase responses and motor neuron signaling, respectively. Researchers study CNTF binding to understand its role in motoneuron disease, peripheral nerve injury, and retinal degeneration, as well as to develop therapeutic strategies that target this interaction. The specificity of CNTF binding is determined by the structural features of both the cytokine and its receptor, which have been characterized in multiple neuronal cell lines and primary neurons.
ciliary neurotrophic factor binding At A Glance
| GO ID | GO:0070119 |
|---|---|
| GO term | ciliary neurotrophic factor binding |
| Ontology | molecular_function |
| Synonym | CNTF binding |
| Definition | Binding to the cytokine ciliary neurotrophic factor. |
| Major function | Mediates CNTF signaling by recruiting receptor subunits and activating JAK/STAT pathways. |
| Related receptor subunits | CNTFRα, gp130, LIFRβ, IL-6R |
| Downstream pathways | JAK/STAT3, MAPK, PI3K/AKT |
| Cellular contexts | Neurons, adipocytes, hepatocytes, muscle cells |
What Is GO:0070119?
GO:0070119, ciliary neurotrophic factor binding, is defined as the molecular function of selectively interacting with the cytokine ciliary neurotrophic factor (CNTF). This binding typically occurs through the CNTF receptor complex, which includes the ligand-specific CNTFRα subunit and the signal-transducing subunits gp130 and LIFRβ. In some contexts, CNTF can also bind to the interleukin-6 receptor (IL-6R), expanding its range of target cells. The term encompasses both high-affinity and low-affinity binding events that lead to receptor activation and downstream signaling. It is a molecular_function term in the Gene Ontology, reflecting the biochemical activity of binding rather than a biological process or cellular component.
Why Is ciliary neurotrophic factor binding Important in Cell Biology?
CNTF binding is a critical molecular event that initiates signaling cascades controlling neuronal survival, regeneration, and metabolic homeostasis. Its importance is underscored by its involvement in motoneuron disease, where impaired CNTF signaling contributes to motor neuron degeneration. Additionally, CNTF binding to retinal cells has been explored as a neuroprotective strategy for age-related macular degeneration. In muscle, CNTF receptor α mediates STAT3 activation after nerve injury, highlighting its role in neuromuscular communication. Thus, understanding CNTF binding provides insights into both basic neurobiology and potential therapeutic interventions.
• CNTF binding is the first step in CNTF-mediated neuroprotection, relevant to motoneuron disease and peripheral neuropathies.
• It regulates energy metabolism and insulin sensitivity in adipocytes, linking CNTF signaling to metabolic disorders.
• CNTF binding to hepatocytes modulates acute-phase protein expression, such as fibrinogen, via IL-6 receptor interaction.
• It is a target for neuroprotective therapies in retinal degeneration, including age-related macular degeneration.
• CNTF binding specificity is determined by receptor composition, making it a model for cytokine-receptor interaction studies.
• Dysregulated CNTF binding may contribute to motor neuron disease progression, as suggested by studies in animal models.
• CNTF binding activates STAT3, a transcription factor involved in cell survival and differentiation.
• Research on CNTF binding informs the design of biologics that mimic or block cytokine-receptor interactions.
• It serves as a paradigm for understanding shared receptor usage among IL-6 family cytokines.
• CNTF binding studies have revealed species-specific differences in receptor affinity and signaling.
Molecular Mechanism of ciliary neurotrophic factor binding
Ligand recognition and receptor complex assembly
In simple terms: CNTF binds to a specific receptor subunit, which then recruits two signaling subunits to form an active complex.
CNTF binding begins with the interaction between CNTF and the glycosylphosphatidylinositol-anchored CNTF receptor α (CNTFRα). This binding is highly specific and saturable, as demonstrated in chick ciliary ganglion neurons and sympathetic neurons. The CNTF-CNTFRα complex then recruits gp130 and LIFRβ to form a heterotrimeric or hexameric signaling complex. In hepatocytes, CNTF can alternatively bind to the interleukin-6 receptor (IL-6R), leading to gp130 homodimerization and activation of fibrinogen gene expression. The structural basis of CNTF binding has been reviewed, revealing that CNTF adopts a four-helix bundle fold typical of IL-6 family cytokines, with distinct epitopes for receptor engagement.
Activation of JAK/STAT signaling
In simple terms: Once the receptor complex forms, it turns on enzymes that add phosphate groups to proteins, leading to gene activation.
Upon CNTF binding and receptor complex assembly, Janus kinases (JAKs) associated with gp130 are activated and phosphorylate tyrosine residues on the receptor cytoplasmic domains. This creates docking sites for STAT3, which is then phosphorylated, dimerizes, and translocates to the nucleus to regulate target genes. In muscle, CNTF receptor α contributes to motor neuron STAT3 activation following peripheral nerve lesion, indicating that CNTF binding in muscle can retrogradely signal to motor neurons. This pathway is central to CNTF-mediated neuroprotection and gene regulation.
Regulation by soluble receptors and binding proteins
In simple terms: CNTF binding can be modulated by soluble forms of its receptor that circulate in body fluids.
Soluble CNTFRα (sCNTFRα) can be released from cells and bind CNTF in the extracellular space, potentially modulating its availability and activity. This soluble receptor can either potentiate or inhibit CNTF signaling depending on context. The binding characteristics of CNTF to sympathetic neurons and neuronal cell lines have been studied to understand receptor affinity and specificity. Additionally, the interaction of CNTF with IL-6R in hepatocytes suggests that receptor usage is flexible and can be influenced by the cellular environment.
Structural determinants of binding specificity
In simple terms: The shape and chemical properties of CNTF and its receptor determine how tightly and specifically they interact.
Neurotrophic factor structures, including CNTF, have been analyzed to reveal clues about evolution, binding, specificity, and receptor activation. The binding of CNTF to its receptor involves electrostatic and hydrophobic interactions that confer high affinity. Studies using chick ciliary ganglion neurons identified functional receptors for CNTF, providing early evidence for specific binding sites. These structural insights are critical for designing agonists or antagonists that can modulate CNTF signaling for therapeutic purposes.
Cellular responses to CNTF binding
In simple terms: CNTF binding triggers changes in cells, such as survival, differentiation, or metabolic shifts.
In hMADS adipocytes, CNTF binding leads to biological effects that include altered gene expression and metabolic changes. In neurons, CNTF binding promotes survival and neurite outgrowth. The downstream effects are cell-type specific and depend on the receptor composition and available signaling molecules. For example, in motoneuron disease models, CNTF binding may slow degeneration, although clinical translation has been challenging. In retinal cells, CNTF binding has been explored for neuroprotection in age-related macular degeneration.
Key Genes Involved in GO:0070119 ciliary neurotrophic factor binding
The following genes encode proteins directly involved in ciliary neurotrophic factor binding and its downstream signaling.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CNTF | Ligand that binds to CNTFRα | Central to all studies of GO:0070119; knockout and overexpression models available. |
| CNTFR | Ligand-specific receptor subunit for CNTF | Determines binding specificity; essential for CNTF signaling. |
| IL6ST | gp130 signal-transducing subunit | Shared by multiple cytokines; required for CNTF signaling. |
| LIFR | LIFRβ signal-transducing subunit | Forms heteromeric receptor with gp130 for CNTF. |
| IL6R | Interleukin-6 receptor | Alternative binding partner for CNTF in hepatocytes. |
| JAK1 | Janus kinase 1 | Phosphorylates STAT3 upon CNTF binding. |
| JAK2 | Janus kinase 2 | May also mediate CNTF-induced signaling. |
| STAT3 | Signal transducer and activator of transcription 3 | Key downstream effector of CNTF binding. |
| SOCS3 | Suppressor of cytokine signaling 3 | Negative regulator of CNTF signaling. |
| PTPN11 | SHP-2 phosphatase | Modulates JAK/STAT pathway downstream of CNTF. |
| GRB2 | Adaptor protein | Links CNTF receptor to MAPK pathway. |
| PIK3CA | PI3K catalytic subunit | Mediates PI3K/AKT survival signaling upon CNTF binding. |
| AKT1 | Serine/threonine kinase | Promotes cell survival downstream of CNTF. |
| MAPK1 | ERK2 | Transmits mitogenic signals from CNTF receptor. |
| MAPK3 | ERK1 | Transmits mitogenic signals from CNTF receptor. |
| CNTFR-AS1 | Long non-coding RNA antisense to CNTFR | May regulate CNTFR expression; understudied. |
| NGF | Nerve growth factor | Related neurotrophic factor; comparative studies. |
| BDNF | Brain-derived neurotrophic factor | Related neurotrophic factor; comparative studies. |
How Is ciliary neurotrophic factor binding Regulated?
CNTF binding and signaling are regulated at multiple levels. Soluble CNTFRα can sequester CNTF, while SOCS3 provides negative feedback by inhibiting JAK activity. In muscle, CNTF receptor α expression is upregulated after nerve injury, enhancing STAT3 activation in motor neurons. Additionally, the availability of gp130 and LIFRβ can limit signaling. In adipocytes, CNTF binding effects are modulated by the metabolic state of the cell. These regulatory mechanisms ensure tight control of CNTF responses.
ciliary neurotrophic factor binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CNTF | Motoneuron disease | Knockout mouse, overexpression in motor neurons |
| CNTFR | Peripheral nerve injury | Muscle-specific knockout, point mutation |
| IL6ST | Inflammatory and metabolic disorders | Conditional knockout in liver or muscle |
| LIFR | Motoneuron disease | Knock-in of patient mutations |
| IL6R | Acute-phase response in hepatocytes | Hepatocyte-specific knockout |
Motoneuron disease
CNTF binding and signaling are implicated in motoneuron disease, where reduced CNTF support may contribute to motor neuron degeneration. Studies in animal models suggest that CNTF administration can slow disease progression, although clinical trials have shown limited efficacy. The molecular function of CNTF binding is therefore a target for understanding disease mechanisms and developing therapies.
Peripheral nerve injury
Following peripheral nerve lesion, CNTF receptor α in muscle contributes to motor neuron STAT3 activation, which is important for nerve regeneration. Dysregulation of CNTF binding may impair regenerative responses, making it a focus for therapeutic intervention.
Age-related macular degeneration
CNTF binding has been explored for neuroprotection in retinal degeneration. Preclinical studies suggest that CNTF can protect photoreceptors, and clinical trials have investigated CNTF implants for age-related macular degeneration. The binding of CNTF to retinal cells is a key step in mediating these protective effects.
Metabolic disorders
CNTF binding to adipocytes influences lipid metabolism and insulin sensitivity, linking this molecular function to obesity and type 2 diabetes. Modulating CNTF binding could have therapeutic potential in metabolic diseases.
From ciliary neurotrophic factor binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CNTF binding require CNTFRα in vivo? | CNTFR knockout mouse |
| How does a point mutation in CNTF affect receptor binding? | Point-mutation knock-in cell line |
| Can soluble CNTFRα modulate CNTF signaling? | Overexpression of soluble CNTFRα |
| What is the role of CNTF binding in motor neurons? | Motor neuron-specific CNTF overexpression |
| How does CNTF binding affect adipocyte metabolism? | hMADS adipocytes with CNTF treatment |
| Does CNTF bind to IL-6R in hepatocytes? | IL-6R knockout hepatocytes |
How to Study the ciliary neurotrophic factor binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioligand binding assay | Affinity and receptor number | Characterizing CNTF binding on neurons |
| Surface plasmon resonance | Kinetic constants (kon, koff) | Real-time CNTF-receptor interaction |
| Western blot | Phosphorylation of STAT3/JAK | Assessing pathway activation |
| Immunoprecipitation | Receptor complex composition | Identifying gp130/LIFRβ association |
| RNA-seq | Transcriptional changes | Gene expression profiling after CNTF treatment |
| CRISPR knockout | Gene function | Validating receptor subunits in CNTF binding |
| Overexpression | Gain-of-function | Studying soluble CNTFRα effects |
| Structural biology (cryo-EM) | 3D structure of complex | Understanding binding interfaces |
Binding assays
Radiolabeled or fluorescently labeled CNTF can be used in saturation binding assays to measure affinity and receptor density on cells, as performed on sympathetic neurons and neuronal cell lines. Surface plasmon resonance (SPR) can determine kinetic constants for CNTF-receptor interactions.
Signal transduction analysis
Western blotting for phosphorylated STAT3 and JAKs is used to assess CNTF-induced signaling. Immunoprecipitation can reveal receptor complex composition. These methods have been applied in muscle and neuronal tissues.
Gene expression profiling
RNA-seq or microarray can identify genes regulated by CNTF binding, such as fibrinogen in hepatocytes or metabolic genes in adipocytes. This provides a global view of downstream effects.
Structural biology
X-ray crystallography or cryo-EM can resolve the structure of CNTF in complex with its receptor, revealing binding interfaces. Reviews of neurotrophic factor structures summarize such insights.
How CRISPR Can Be Used to Study GO:0070119 ciliary neurotrophic factor binding
Knockout
CRISPR knockout of CNTF, CNTFR, IL6ST, or LIFR can abolish CNTF binding and signaling, providing definitive evidence for their roles. For example, CNTFR knockout cells fail to respond to CNTF, as shown in various neuronal models.
Point Mutation
Introducing point mutations in the CNTF binding interface or in receptor subunits can dissect the molecular determinants of binding specificity. This approach is useful for mimicking human disease-associated variants.
Knock-in
Knock-in of tagged CNTF or CNTFR (e.g., HA or GFP) allows visualization and purification of the binding complex. This can be combined with live-cell imaging to track CNTF binding dynamics.
Overexpression
Overexpression of CNTF or its receptors can enhance signaling and is used to study gain-of-function effects, such as neuroprotection in retinal cells or metabolic changes in adipocytes.
How EDITGENE Supports ciliary neurotrophic factor binding Research
Researchers studying ciliary neurotrophic factor binding-related genes often need to determine whether a candidate gene is causally involved in CNTF signaling or whether a specific mutation alters binding affinity. EDITGENE provides a comprehensive suite of CRISPR services to address these questions, from generating knockout cell lines to creating precise point mutations and knock-in reporters.
Contact EDITGENE today to design your custom CRISPR model for ciliary neurotrophic factor binding research.
Frequently Asked Questions About ciliary neurotrophic factor binding
What is ciliary neurotrophic factor binding?
Ciliary neurotrophic factor binding (GO:0070119) is the molecular function of selectively interacting with the cytokine CNTF, typically through the CNTF receptor complex.
What genes are involved in ciliary neurotrophic factor binding?
Key genes include CNTF, CNTFR, IL6ST (gp130), LIFR, and IL6R, which encode the ligand and receptor subunits.
What is the GO ID for ciliary neurotrophic factor binding?
The Gene Ontology ID is GO:0070119.
How does CNTF binding activate signaling?
CNTF binding induces receptor complex assembly, activating JAK kinases that phosphorylate STAT3, which then regulates gene expression.
Which diseases are associated with CNTF binding?
CNTF binding is implicated in motoneuron disease, peripheral nerve injury, age-related macular degeneration, and metabolic disorders.
What cell types express CNTF receptors?
CNTF receptors are expressed in neurons, adipocytes, hepatocytes, and muscle cells, among others.
Can CNTF bind to the IL-6 receptor?
Yes, in hepatocytes, CNTF can bind to the interleukin-6 receptor to regulate fibrinogen gene expression.
What methods are used to study CNTF binding?
Common methods include radioligand binding assays, surface plasmon resonance, Western blotting for STAT3 phosphorylation, and CRISPR knockout models.
What are the research models for CNTF binding?
Models include knockout mice, point-mutation cell lines, overexpression systems, and primary neuronal cultures.
How can EDITGENE help with CNTF binding research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, and library screening services to study CNTF binding and its downstream effects.
Conclusion
Ciliary neurotrophic factor binding (GO:0070119) is a fundamental molecular function that initiates signaling cascades critical for neuronal survival, metabolic regulation, and tissue repair. Its involvement in diseases such as motoneuron disease and retinal degeneration underscores its therapeutic potential. Continued research using advanced CRISPR models and binding assays will further elucidate the precise mechanisms and enable targeted interventions.
References
- 1. Perugini J et al.. 2019. Biological Effects of Ciliary Neurotrophic Factor on hMADS Adipocytes.. Front Endocrinol (Lausanne) 10:768 PMID: 31781039
- 2. Sendtner M. 2014. Motoneuron disease.. Handb Exp Pharmacol 220:411-41 PMID: 24668481
- 3. Lin JB et al.. 2022. Neuroprotection for Age-Related Macular Degeneration.. Ophthalmol Sci 2(4):100192 PMID: 36570623
- 4. Koshlukova S et al.. 1996. Identification of functional receptors for ciliary neurotrophic factor on chick ciliary ganglion neurons.. Neuroscience 72(3):821-32 PMID: 9157328
- 5. Lee N et al.. 2019. Muscle ciliary neurotrophic factor receptor α contributes to motor neuron STAT3 activation following peripheral nerve lesion.. Eur J Neurosci 49(9):1084-1090 PMID: 30554447
- 6. Wong V et al.. 1995. Binding characteristics of ciliary neurotrophic factor to sympathetic neurons and neuronal cell lines.. J Biol Chem 270(1):313-8 PMID: 7814393
- 7. Nesbitt JE et al.. 1993. Ciliary neurotrophic factor regulates fibrinogen gene expression in hepatocytes by binding to the interleukin-6 receptor.. Biochem Biophys Res Commun 190(2):544-50 PMID: 8427597
- 8. Butte MJ. 2001. Neurotrophic factor structures reveal clues to evolution, binding, specificity, and receptor activation.. Cell Mol Life Sci 58(8):1003-13 PMID: 11529493
